nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—ESR1—urinary bladder cancer	0.708	1	CbGaD
Fluoxymesterone—AR—scrotum—urinary bladder cancer	0.0226	0.235	CbGeAlD
Fluoxymesterone—PRLR—prostate gland—urinary bladder cancer	0.0157	0.163	CbGeAlD
Fluoxymesterone—AR—penis—urinary bladder cancer	0.0102	0.106	CbGeAlD
Fluoxymesterone—Oligospermia—Gemcitabine—urinary bladder cancer	0.00503	0.0837	CcSEcCtD
Fluoxymesterone—NR3C1—urine—urinary bladder cancer	0.00491	0.0511	CbGeAlD
Fluoxymesterone—Azoospermia—Thiotepa—urinary bladder cancer	0.00465	0.0774	CcSEcCtD
Fluoxymesterone—Azoospermia—Gemcitabine—urinary bladder cancer	0.00392	0.0651	CcSEcCtD
Fluoxymesterone—Azoospermia—Cisplatin—urinary bladder cancer	0.00365	0.0607	CcSEcCtD
Fluoxymesterone—SHBG—prostate gland—urinary bladder cancer	0.00339	0.0353	CbGeAlD
Fluoxymesterone—Oligospermia—Methotrexate—urinary bladder cancer	0.00257	0.0428	CcSEcCtD
Fluoxymesterone—AR—prostate gland—urinary bladder cancer	0.00243	0.0253	CbGeAlD
Fluoxymesterone—Oligospermia—Epirubicin—urinary bladder cancer	0.00241	0.0401	CcSEcCtD
Fluoxymesterone—ESR1—prostate gland—urinary bladder cancer	0.00239	0.0248	CbGeAlD
Fluoxymesterone—Oligospermia—Doxorubicin—urinary bladder cancer	0.00223	0.0371	CcSEcCtD
Fluoxymesterone—AR—seminal vesicle—urinary bladder cancer	0.00206	0.0214	CbGeAlD
Fluoxymesterone—Azoospermia—Methotrexate—urinary bladder cancer	0.002	0.0333	CcSEcCtD
Fluoxymesterone—Azoospermia—Epirubicin—urinary bladder cancer	0.00187	0.0312	CcSEcCtD
Fluoxymesterone—SHBG—female reproductive system—urinary bladder cancer	0.00185	0.0192	CbGeAlD
Fluoxymesterone—AR—epithelium—urinary bladder cancer	0.00179	0.0186	CbGeAlD
Fluoxymesterone—NR3C1—prostate gland—urinary bladder cancer	0.00176	0.0183	CbGeAlD
Fluoxymesterone—ESR1—epithelium—urinary bladder cancer	0.00176	0.0183	CbGeAlD
Fluoxymesterone—Azoospermia—Doxorubicin—urinary bladder cancer	0.00173	0.0288	CcSEcCtD
Fluoxymesterone—AR—smooth muscle tissue—urinary bladder cancer	0.00172	0.0179	CbGeAlD
Fluoxymesterone—ESR1—smooth muscle tissue—urinary bladder cancer	0.00169	0.0176	CbGeAlD
Fluoxymesterone—SHBG—vagina—urinary bladder cancer	0.00167	0.0174	CbGeAlD
Fluoxymesterone—AR—renal system—urinary bladder cancer	0.00166	0.0172	CbGeAlD
Fluoxymesterone—AR—urethra—urinary bladder cancer	0.00163	0.0169	CbGeAlD
Fluoxymesterone—ESR1—renal system—urinary bladder cancer	0.00163	0.0169	CbGeAlD
Fluoxymesterone—NR3C1—seminal vesicle—urinary bladder cancer	0.00149	0.0155	CbGeAlD
Fluoxymesterone—Amenorrhoea—Thiotepa—urinary bladder cancer	0.00143	0.0237	CcSEcCtD
Fluoxymesterone—AR—female reproductive system—urinary bladder cancer	0.00133	0.0138	CbGeAlD
Fluoxymesterone—ESR1—female reproductive system—urinary bladder cancer	0.0013	0.0136	CbGeAlD
Fluoxymesterone—NR3C1—epithelium—urinary bladder cancer	0.0013	0.0135	CbGeAlD
Fluoxymesterone—NR3C1—smooth muscle tissue—urinary bladder cancer	0.00125	0.013	CbGeAlD
Fluoxymesterone—AR—vagina—urinary bladder cancer	0.0012	0.0125	CbGeAlD
Fluoxymesterone—NR3C1—renal system—urinary bladder cancer	0.0012	0.0125	CbGeAlD
Fluoxymesterone—NR3C1—urethra—urinary bladder cancer	0.00118	0.0123	CbGeAlD
Fluoxymesterone—ESR1—vagina—urinary bladder cancer	0.00118	0.0123	CbGeAlD
Fluoxymesterone—Alopecia—Mitomycin—urinary bladder cancer	0.00111	0.0184	CcSEcCtD
Fluoxymesterone—NR3C1—female reproductive system—urinary bladder cancer	0.000962	0.01	CbGeAlD
Fluoxymesterone—NR3C1—vagina—urinary bladder cancer	0.00087	0.00905	CbGeAlD
Fluoxymesterone—Headache—Valrubicin—urinary bladder cancer	0.000809	0.0135	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Gemcitabine—urinary bladder cancer	0.000791	0.0132	CcSEcCtD
Fluoxymesterone—AR—lymph node—urinary bladder cancer	0.000777	0.00808	CbGeAlD
Fluoxymesterone—Nausea—Valrubicin—urinary bladder cancer	0.000767	0.0128	CcSEcCtD
Fluoxymesterone—ESR1—lymph node—urinary bladder cancer	0.000763	0.00793	CbGeAlD
Fluoxymesterone—Seborrhoeic dermatitis—Epirubicin—urinary bladder cancer	0.000741	0.0123	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Cisplatin—urinary bladder cancer	0.000737	0.0123	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Doxorubicin—urinary bladder cancer	0.000685	0.0114	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Etoposide—urinary bladder cancer	0.000675	0.0112	CcSEcCtD
Fluoxymesterone—Haemoglobin—Thiotepa—urinary bladder cancer	0.000633	0.0105	CcSEcCtD
Fluoxymesterone—Haemorrhage—Thiotepa—urinary bladder cancer	0.00063	0.0105	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Epirubicin—urinary bladder cancer	0.000575	0.00955	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Epirubicin—urinary bladder cancer	0.000575	0.00955	CcSEcCtD
Fluoxymesterone—NR3C1—lymph node—urinary bladder cancer	0.000563	0.00585	CbGeAlD
Fluoxymesterone—Headache—Mitomycin—urinary bladder cancer	0.000557	0.00927	CcSEcCtD
Fluoxymesterone—Alopecia—Thiotepa—urinary bladder cancer	0.000556	0.00925	CcSEcCtD
Fluoxymesterone—Haemoglobin—Gemcitabine—urinary bladder cancer	0.000532	0.00885	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Doxorubicin—urinary bladder cancer	0.000532	0.00884	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Doxorubicin—urinary bladder cancer	0.000532	0.00884	CcSEcCtD
Fluoxymesterone—Haemorrhage—Gemcitabine—urinary bladder cancer	0.00053	0.00881	CcSEcCtD
Fluoxymesterone—Nausea—Mitomycin—urinary bladder cancer	0.000528	0.00879	CcSEcCtD
Fluoxymesterone—Haemoglobin—Fluorouracil—urinary bladder cancer	0.000523	0.0087	CcSEcCtD
Fluoxymesterone—Haemorrhage—Fluorouracil—urinary bladder cancer	0.000521	0.00866	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Methotrexate—urinary bladder cancer	0.000483	0.00803	CcSEcCtD
Fluoxymesterone—Alopecia—Gemcitabine—urinary bladder cancer	0.000468	0.00778	CcSEcCtD
Fluoxymesterone—Anxiety—Thiotepa—urinary bladder cancer	0.000465	0.00773	CcSEcCtD
Fluoxymesterone—Alopecia—Fluorouracil—urinary bladder cancer	0.00046	0.00765	CcSEcCtD
Fluoxymesterone—Alopecia—Cisplatin—urinary bladder cancer	0.000436	0.00725	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.000405	0.00673	CcSEcCtD
Fluoxymesterone—Paraesthesia—Thiotepa—urinary bladder cancer	0.000402	0.00668	CcSEcCtD
Fluoxymesterone—Alopecia—Etoposide—urinary bladder cancer	0.0004	0.00665	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.000379	0.0063	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000376	0.00626	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00037	0.00615	CcSEcCtD
Fluoxymesterone—Anxiety—Cisplatin—urinary bladder cancer	0.000365	0.00606	CcSEcCtD
Fluoxymesterone—Danazol—ESR1—urinary bladder cancer	0.000351	0.281	CrCbGaD
Fluoxymesterone—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000351	0.00583	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.00035	0.00583	CcSEcCtD
Fluoxymesterone—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000338	0.00562	CcSEcCtD
Fluoxymesterone—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000332	0.00552	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00033	0.00548	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000321	0.00534	CcSEcCtD
Fluoxymesterone—Paraesthesia—Cisplatin—urinary bladder cancer	0.000315	0.00524	CcSEcCtD
Fluoxymesterone—Medroxyprogesterone Acetate—ESR1—urinary bladder cancer	0.000315	0.252	CrCbGaD
Fluoxymesterone—Paraesthesia—Etoposide—urinary bladder cancer	0.000288	0.0048	CcSEcCtD
Fluoxymesterone—Headache—Thiotepa—urinary bladder cancer	0.00028	0.00466	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000273	0.00453	CcSEcCtD
Fluoxymesterone—Haemoglobin—Methotrexate—urinary bladder cancer	0.000272	0.00453	CcSEcCtD
Fluoxymesterone—Haemorrhage—Methotrexate—urinary bladder cancer	0.000271	0.0045	CcSEcCtD
Fluoxymesterone—Nausea—Thiotepa—urinary bladder cancer	0.000266	0.00442	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000258	0.0043	CcSEcCtD
Fluoxymesterone—Haemoglobin—Epirubicin—urinary bladder cancer	0.000255	0.00424	CcSEcCtD
Fluoxymesterone—Haemorrhage—Epirubicin—urinary bladder cancer	0.000253	0.00422	CcSEcCtD
Fluoxymesterone—Alopecia—Methotrexate—urinary bladder cancer	0.000239	0.00398	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Etoposide—urinary bladder cancer	0.000237	0.00394	CcSEcCtD
Fluoxymesterone—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000236	0.00392	CcSEcCtD
Fluoxymesterone—Headache—Gemcitabine—urinary bladder cancer	0.000236	0.00392	CcSEcCtD
Fluoxymesterone—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000235	0.0039	CcSEcCtD
Fluoxymesterone—Headache—Fluorouracil—urinary bladder cancer	0.000232	0.00385	CcSEcCtD
Fluoxymesterone—Alopecia—Epirubicin—urinary bladder cancer	0.000224	0.00373	CcSEcCtD
Fluoxymesterone—Nausea—Gemcitabine—urinary bladder cancer	0.000223	0.00372	CcSEcCtD
Fluoxymesterone—Nausea—Fluorouracil—urinary bladder cancer	0.00022	0.00365	CcSEcCtD
Fluoxymesterone—Nausea—Cisplatin—urinary bladder cancer	0.000208	0.00346	CcSEcCtD
Fluoxymesterone—Alopecia—Doxorubicin—urinary bladder cancer	0.000207	0.00345	CcSEcCtD
Fluoxymesterone—Headache—Etoposide—urinary bladder cancer	0.000201	0.00335	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000192	0.0032	CcSEcCtD
Fluoxymesterone—Nausea—Etoposide—urinary bladder cancer	0.000191	0.00317	CcSEcCtD
Fluoxymesterone—Anxiety—Epirubicin—urinary bladder cancer	0.000187	0.00311	CcSEcCtD
Fluoxymesterone—Progesterone—ESR1—urinary bladder cancer	0.000182	0.146	CrCbGaD
Fluoxymesterone—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00018	0.003	CcSEcCtD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—CCND1—urinary bladder cancer	0.00018	0.00134	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000179	0.00133	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—KRAS—urinary bladder cancer	0.000178	0.00133	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—urinary bladder cancer	0.000178	0.00132	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—EP300—urinary bladder cancer	0.000178	0.00132	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000176	0.00131	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—RBX1—urinary bladder cancer	0.000175	0.0013	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000175	0.0013	CbGpPWpGaD
Fluoxymesterone—Triamcinolone—PTGS2—urinary bladder cancer	0.000174	0.14	CrCbGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HRAS—urinary bladder cancer	0.000174	0.00129	CbGpPWpGaD
Fluoxymesterone—Anxiety—Doxorubicin—urinary bladder cancer	0.000173	0.00288	CcSEcCtD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—SRC—urinary bladder cancer	0.000173	0.00128	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Methotrexate—urinary bladder cancer	0.000173	0.00287	CcSEcCtD
Fluoxymesterone—NR3C1—Circadian Clock—EP300—urinary bladder cancer	0.000173	0.00128	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000172	0.00128	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.000171	0.00127	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.000171	0.00127	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—ESR1—urinary bladder cancer	0.00017	0.00126	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—urinary bladder cancer	0.000169	0.00125	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—urinary bladder cancer	0.000169	0.00125	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CXCL8—urinary bladder cancer	0.000168	0.00125	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CCND1—urinary bladder cancer	0.000168	0.00125	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—ERBB2—urinary bladder cancer	0.000168	0.00125	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000167	0.00124	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000167	0.00277	CcSEcCtD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CXCL8—urinary bladder cancer	0.000166	0.00123	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—FAS—urinary bladder cancer	0.000166	0.00123	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—NCOR1—urinary bladder cancer	0.000166	0.00123	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—EP300—urinary bladder cancer	0.000166	0.00123	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TSC1—urinary bladder cancer	0.000165	0.00122	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—IL2—urinary bladder cancer	0.000165	0.00122	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000164	0.00122	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000163	0.00121	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CDKN1A—urinary bladder cancer	0.000163	0.00121	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—PTEN—urinary bladder cancer	0.000162	0.00121	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Epirubicin—urinary bladder cancer	0.000162	0.00269	CcSEcCtD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL2—urinary bladder cancer	0.000161	0.0012	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—CCND1—urinary bladder cancer	0.000161	0.00119	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000161	0.00119	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL2—urinary bladder cancer	0.000159	0.00118	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—JAG1—urinary bladder cancer	0.000157	0.00117	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CCND1—urinary bladder cancer	0.000157	0.00117	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—EP300—urinary bladder cancer	0.000155	0.00115	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—EP300—urinary bladder cancer	0.000155	0.00115	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CCND1—urinary bladder cancer	0.000155	0.00115	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—urinary bladder cancer	0.000153	0.00113	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MMP9—urinary bladder cancer	0.000152	0.00113	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—HRAS—urinary bladder cancer	0.000152	0.00113	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—PTEN—urinary bladder cancer	0.000151	0.00112	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—SRC—urinary bladder cancer	0.00015	0.00112	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MMP9—urinary bladder cancer	0.00015	0.00111	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00015	0.00249	CcSEcCtD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—PTEN—urinary bladder cancer	0.000149	0.00111	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—CCND1—urinary bladder cancer	0.000149	0.0011	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.000148	0.0011	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.000148	0.0011	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—urinary bladder cancer	0.000147	0.00109	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—urinary bladder cancer	0.000146	0.00109	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.000145	0.00108	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000145	0.00108	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—EP300—urinary bladder cancer	0.000144	0.00107	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—FGFR3—urinary bladder cancer	0.000143	0.00106	CbGpPWpGaD
Fluoxymesterone—Betamethasone—PTGS2—urinary bladder cancer	0.000143	0.114	CrCbGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—EP300—urinary bladder cancer	0.000142	0.00106	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000142	0.00106	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000142	0.00105	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000142	0.00236	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000141	0.00105	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.000141	0.00105	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL2—urinary bladder cancer	0.00014	0.00104	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.00014	0.00104	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000138	0.00103	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—MYC—urinary bladder cancer	0.000135	0.001	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000135	0.001	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—FGFR3—urinary bladder cancer	0.000134	0.000995	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000133	0.000988	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—SRC—urinary bladder cancer	0.000133	0.000987	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000133	0.00221	CcSEcCtD
Fluoxymesterone—NR3C1—Adipogenesis—PPARG—urinary bladder cancer	0.000133	0.000984	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.000132	0.00098	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—EGFR—urinary bladder cancer	0.000132	0.00098	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—urinary bladder cancer	0.000132	0.000978	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.000131	0.000976	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—MYC—urinary bladder cancer	0.000129	0.000957	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000129	0.000955	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—S100B—urinary bladder cancer	0.000127	0.000944	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—RB1—urinary bladder cancer	0.000127	0.000942	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000127	0.00094	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—EGFR—urinary bladder cancer	0.000126	0.000936	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MYC—urinary bladder cancer	0.000126	0.000935	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IGF1—urinary bladder cancer	0.000126	0.000934	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—EP300—urinary bladder cancer	0.000125	0.000931	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MYC—urinary bladder cancer	0.000124	0.000921	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000124	0.000919	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000123	0.000916	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000123	0.00204	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000122	0.000905	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CREBBP—urinary bladder cancer	0.000122	0.000904	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CDH1—urinary bladder cancer	0.000121	0.000897	CbGpPWpGaD
Fluoxymesterone—Headache—Methotrexate—urinary bladder cancer	0.000121	0.00201	CcSEcCtD
Fluoxymesterone—AR—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000115	0.000856	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000115	0.000855	CbGpPWpGaD
Fluoxymesterone—Nausea—Methotrexate—urinary bladder cancer	0.000114	0.0019	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—NCOR1—urinary bladder cancer	0.000114	0.000849	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.000114	0.000848	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.000114	0.000845	CbGpPWpGaD
Fluoxymesterone—Headache—Epirubicin—urinary bladder cancer	0.000113	0.00188	CcSEcCtD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.000112	0.000832	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.00011	0.000819	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	0.00011	0.000818	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.00011	0.000817	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000109	0.000812	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000109	0.000809	CbGpPWpGaD
Fluoxymesterone—Nausea—Epirubicin—urinary bladder cancer	0.000107	0.00178	CcSEcCtD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	0.000106	0.00079	CbGpPWpGaD
Fluoxymesterone—Headache—Doxorubicin—urinary bladder cancer	0.000104	0.00174	CcSEcCtD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—urinary bladder cancer	0.000103	0.000768	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000103	0.000767	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ERBB2—urinary bladder cancer	0.000102	0.000757	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—urinary bladder cancer	0.000102	0.000756	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	0.000101	0.000753	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000101	0.00075	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TERT—urinary bladder cancer	0.000101	0.000748	CbGpPWpGaD
Fluoxymesterone—Nausea—Doxorubicin—urinary bladder cancer	9.9e-05	0.00165	CcSEcCtD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	9.88e-05	0.000734	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—ERBB2—urinary bladder cancer	9.55e-05	0.000709	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	9.5e-05	0.000706	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	9.38e-05	0.000697	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—HRAS—urinary bladder cancer	9.36e-05	0.000695	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FGFR3—urinary bladder cancer	9.24e-05	0.000687	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL2—urinary bladder cancer	9.24e-05	0.000686	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	9.13e-05	0.000678	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—CDKN1A—urinary bladder cancer	9.11e-05	0.000677	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ESR1—urinary bladder cancer	8.98e-05	0.000667	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—urinary bladder cancer	8.97e-05	0.000666	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NCOR1—urinary bladder cancer	8.9e-05	0.000661	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—ESR2—urinary bladder cancer	8.88e-05	0.000659	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	8.84e-05	0.000656	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	8.83e-05	0.000656	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	8.81e-05	0.000654	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—ESR2—urinary bladder cancer	8.75e-05	0.000649	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	8.74e-05	0.000649	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CDKN1A—urinary bladder cancer	8.71e-05	0.000647	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PTEN—urinary bladder cancer	8.69e-05	0.000646	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	8.64e-05	0.000642	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	8.49e-05	0.00063	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	8.4e-05	0.000624	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—PTGS2—urinary bladder cancer	8.31e-05	0.0666	CrCbGaD
Fluoxymesterone—PRLR—Immune System—EP300—urinary bladder cancer	8.29e-05	0.000616	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	8.19e-05	0.000608	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	8.17e-05	0.000607	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—CDKN1A—urinary bladder cancer	8.17e-05	0.000606	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	8.16e-05	0.000606	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PTEN—urinary bladder cancer	8.15e-05	0.000605	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—SRC—urinary bladder cancer	8.06e-05	0.000599	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	8.02e-05	0.000595	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	7.96e-05	0.000591	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CREBBP—urinary bladder cancer	7.87e-05	0.000584	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	7.81e-05	0.00058	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	7.78e-05	0.000578	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF1—urinary bladder cancer	7.77e-05	0.000577	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	7.49e-05	0.000557	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	7.32e-05	0.000544	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	7.26e-05	0.000539	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	7.16e-05	0.000532	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—RHOA—urinary bladder cancer	7.12e-05	0.000529	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EGFR—urinary bladder cancer	7.07e-05	0.000525	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TNF—urinary bladder cancer	7.04e-05	0.000523	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	7.03e-05	0.000522	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—ESR1—urinary bladder cancer	6.99e-05	0.000519	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NCOR1—urinary bladder cancer	6.86e-05	0.000509	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	6.82e-05	0.000506	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	6.81e-05	0.000505	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	6.8e-05	0.000505	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	6.79e-05	0.000504	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	6.76e-05	0.000502	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NCOR1—urinary bladder cancer	6.75e-05	0.000501	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—KRAS—urinary bladder cancer	6.67e-05	0.000496	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	6.66e-05	0.000494	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—EGFR—urinary bladder cancer	6.62e-05	0.000492	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ERBB2—urinary bladder cancer	6.59e-05	0.000489	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	6.47e-05	0.000481	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PPARG—urinary bladder cancer	6.38e-05	0.000474	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SMC1A—urinary bladder cancer	6.37e-05	0.000473	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	6.29e-05	0.000467	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	6.29e-05	0.000467	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—KRAS—urinary bladder cancer	6.26e-05	0.000465	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCL8—urinary bladder cancer	6.25e-05	0.000464	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—CREBBP—urinary bladder cancer	6.13e-05	0.000455	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	6.08e-05	0.000452	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	6.01e-05	0.000446	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL2—urinary bladder cancer	5.97e-05	0.000444	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCND1—urinary bladder cancer	5.82e-05	0.000432	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HDAC4—urinary bladder cancer	5.73e-05	0.000426	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HRAS—urinary bladder cancer	5.67e-05	0.000421	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MMP9—urinary bladder cancer	5.65e-05	0.00042	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	5.64e-05	0.000419	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN1A—urinary bladder cancer	5.63e-05	0.000418	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PTEN—urinary bladder cancer	5.62e-05	0.000417	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	5.59e-05	0.000415	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ESR2—urinary bladder cancer	5.55e-05	0.000412	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	5.52e-05	0.00041	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EP300—urinary bladder cancer	5.36e-05	0.000398	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—HRAS—urinary bladder cancer	5.32e-05	0.000395	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—ESR1—urinary bladder cancer	5.3e-05	0.000394	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	5.25e-05	0.00039	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SRC—urinary bladder cancer	5.21e-05	0.000387	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	5.21e-05	0.000387	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PPARG—urinary bladder cancer	4.91e-05	0.000365	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SMC1A—urinary bladder cancer	4.91e-05	0.000364	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PPARG—urinary bladder cancer	4.84e-05	0.000359	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SMC1A—urinary bladder cancer	4.83e-05	0.000359	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GLI1—urinary bladder cancer	4.81e-05	0.000357	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	4.72e-05	0.000351	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MYC—urinary bladder cancer	4.67e-05	0.000347	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	4.65e-05	0.000345	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	4.63e-05	0.000344	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EGFR—urinary bladder cancer	4.57e-05	0.000339	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KRAS—urinary bladder cancer	4.32e-05	0.00032	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NCOR1—urinary bladder cancer	4.29e-05	0.000318	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—ESR2—urinary bladder cancer	4.28e-05	0.000318	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ESR2—urinary bladder cancer	4.21e-05	0.000313	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ERCC2—urinary bladder cancer	4.03e-05	0.000299	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—urinary bladder cancer	3.84e-05	0.000285	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HRAS—urinary bladder cancer	3.67e-05	0.000272	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MYC—urinary bladder cancer	3.64e-05	0.00027	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ESR1—urinary bladder cancer	3.37e-05	0.00025	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NCOR1—urinary bladder cancer	3.3e-05	0.000245	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RBX1—urinary bladder cancer	3.29e-05	0.000245	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NCOR1—urinary bladder cancer	3.25e-05	0.000241	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—ERCC2—urinary bladder cancer	3.1e-05	0.00023	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TSC1—urinary bladder cancer	3.1e-05	0.00023	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PPARG—urinary bladder cancer	3.07e-05	0.000228	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ERCC2—urinary bladder cancer	3.06e-05	0.000227	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—CREBBP—urinary bladder cancer	2.95e-05	0.000219	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—JAG1—urinary bladder cancer	2.95e-05	0.000219	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MYC—urinary bladder cancer	2.8e-05	0.000208	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MYC—urinary bladder cancer	2.76e-05	0.000205	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ESR1—urinary bladder cancer	2.55e-05	0.00019	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—S100B—urinary bladder cancer	2.39e-05	0.000177	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPARG—urinary bladder cancer	2.37e-05	0.000176	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPARG—urinary bladder cancer	2.33e-05	0.000173	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—CREBBP—urinary bladder cancer	2.27e-05	0.000169	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—CREBBP—urinary bladder cancer	2.24e-05	0.000166	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NCOR1—urinary bladder cancer	2.15e-05	0.000159	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TERT—urinary bladder cancer	1.89e-05	0.00014	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MYC—urinary bladder cancer	1.75e-05	0.00013	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGFR3—urinary bladder cancer	1.74e-05	0.000129	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CREBBP—urinary bladder cancer	1.48e-05	0.00011	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF1—urinary bladder cancer	1.46e-05	0.000108	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MYC—urinary bladder cancer	1.35e-05	0.0001	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RHOA—urinary bladder cancer	1.34e-05	9.93e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MYC—urinary bladder cancer	1.33e-05	9.86e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB2—urinary bladder cancer	1.24e-05	9.19e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCL8—urinary bladder cancer	1.17e-05	8.72e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL2—urinary bladder cancer	1.12e-05	8.33e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCND1—urinary bladder cancer	1.09e-05	8.12e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MMP9—urinary bladder cancer	1.06e-05	7.88e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.06e-05	7.85e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTEN—urinary bladder cancer	1.06e-05	7.84e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EP300—urinary bladder cancer	1.01e-05	7.47e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SRC—urinary bladder cancer	9.79e-06	7.27e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MYC—urinary bladder cancer	8.77e-06	6.51e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGFR—urinary bladder cancer	8.58e-06	6.37e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KRAS—urinary bladder cancer	8.1e-06	6.02e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—urinary bladder cancer	7.2e-06	5.35e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HRAS—urinary bladder cancer	6.89e-06	5.11e-05	CbGpPWpGaD
